Status:
COMPLETED
Single Rising Dose Study of BI 144807 Powder in Bottle in Healthy Male Volunteers
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Healthy
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
This first-in-man trial forms the basis for potential clinical development of BI 144807 in the indications of asthma and allergic rhinitis. The safety, tolerability, pharmacokinetics, and pharmacodyna...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- 1\. healthy male subjects
- Exclusion criteria:
- 1\. any relevant deviation from healthy conditions
Exclusion
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT01480648
Start Date
November 1 2011
Last Update
November 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1313.1.1 Boehringer Ingelheim Investigational Site
Biberach, Germany